CoChat

The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index; 14 of the 26 sources its claims cite were checked for support.

Effect of Supplementation with Probiotics in Patients with Schizophrenia: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials

Open access

Abstract

Supplementation with probiotics seems to confer protective effects in individuals with schizophrenia (SZ), although available results are inconclusive. The aim of this study was to systematically review existing randomized clinical trials (RCTs) to critically assess the effect of probiotics on psychiatric symptoms, anthropometric indicators, lipid profiles, glycemic indices, inflammation, and oxidative stress in adults with SZ. A systematic search was conducted in four databases from inception until January 2025. Six RCTs were included in the quantitative analysis that demonstrated beneficial effects of probiotics on SZ severity determined via the Positive and Negative Syndrome Scale (PANSS), with significant reductions in PANSS (MD = −0.50, p = 0.001), PANSS Negative (MD = −0.31, p = 0.050), and PANSS General scores (MD = −0.33, p = 0.036), alongside reductions in body weight (MD = −0.92, p = 0.000), body mass index (MD = −0.53, p = 0.016), and total cholesterol (SMD = −0.34, p = 0.005). Furthermore, probiotic interventions reduced baseline glucose (SMD = −0.59, p = 0.000), insulin (MD = −0.68, p = 0.000), and measures of insulin sensitivity/resistance and significantly improved biomarkers of inflammation and oxidative stress. To summarize, this meta-analysis suggests that probiotics may confer beneficial effects in patients with SZ through improving psychiatric symptoms as well as markers of body weight, lipid and glucose metabolism, inflammation, and oxidative stress.

Overview

CoChat Summary

## TL;DR

This systematic review and meta-analysis of 6 randomized controlled trials found that probiotics, often given with other supplements, were associated with improvements in several schizophrenia-related and metabolic outcomes. The pooled results showed reductions in PANSS total, PANSS Negative, PANSS General, BMI, weight, total cholesterol, glucose-related measures, hs-CRP, and oxidative stress markers, but not PANSS Positive or BPRS.

## Key findings

  • Six RCTs with 361 patients with schizophrenia were included; 183 were in intervention groups and 178 in control groups.
  • Psychiatric symptoms improved for some measures: total PANSS decreased (MD = −0.50, p = 0.001), PANSS Negative decreased (MD = −0.31, p = 0.050), and PANSS General decreased (MD = −0.33, p = 0.036); PANSS Positive and BPRS did not differ significantly.
  • Anthropometric and lipid outcomes improved: BMI decreased (MD = −0.53, p = 0.016), weight decreased (MD = −0.92, p = 0.000), and total cholesterol decreased (SMD = −0.34, p = 0.005); TGs, LDL-C, VLDL-C, HDL-C, and total/HDL-cholesterol ratio were not significantly changed.
  • Metabolic, inflammatory, and oxidative stress markers also improved: fasting glucose (SMD = −0.59, p = 0.000), HOMA-IR (MD = −0.92, p = 0.002), insulin (MD = −0.68, p = 0.000), IRI (MD = −0.67, p = 0.000), QUICKI (MD = 1.14, p = 0.000), hs-CRP (MD = −0.79, p = 0.000), GSH (MD = 0.53, p = 0.006), TAC (MD = 0.47, p = 0.014), and MDA (MD = −0.47, p = 0.014).

## Methods

  • Systematic review and meta-analysis conducted according to PRISMA, registered in INPLASY (INPLASY202510113), with searches from inception to January 2025 in CENTRAL, PubMed, ScienceDirect, and Web of Science.
  • Included randomized controlled trials in adults with schizophrenia that assessed at least one outcome among psychiatric symptoms, anthropometric indicators, lipid profile, glycemic indices, inflammation, or oxidative stress; 6 RCTs met criteria.
  • Dual-reviewer study selection, quality assessment (RoB2 and Nutri Grade), and data extraction; pooled effect sizes were calculated in Stata v14.0 and Review Manager 5.4 using a random-effects DerSimonian–Laird model.

## Limitations

  • The paper states that only six RCTs were included and that sample sizes were small.
  • The paper states that co-supplementation with selenium, vitamin D, dietary fiber, or oligofructose may have confounded the effects, making it hard to isolate probiotics alone.
  • The paper states that differences in baseline parameters, probiotic types, and dosages may have contributed to heterogeneity, and that long-term follow-up data were lacking because study duration was 12 weeks.
  • Evident from the text: most interventions combined probiotics with other supplements, so the evidence for probiotics alone is limited.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/foods14101773

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Flow diagram of the study selection, adapted from Ref. [27].
Figure 1 Flow diagram of the study selection, adapted from Ref. [27].CC BY · PubMed Central
Figure 2 (top) Risk of bias summary. (bottom) Risk of bias graph [28,29,30,31,32,33].
Figure 2 (top) Risk of bias summary. (bottom) Risk of bias graph [28,29,30,31,32,33].CC BY · PubMed Central
Figure 3 The forest plot is a visual representation of the effect of probiotic consumption: (A) PANSS; (B) PANSS Negative; (C) PANSS General; (D) PANSS Positive; (E) BPRS [28,29,30,33].
Figure 3 The forest plot is a visual representation of the effect of probiotic consumption: (A) PANSS; (B) PANSS Negative; (C) PANSS General; (D) PANSS Positive; (E) BPRS [28,29,30,33].CC BY · PubMed Central
Figure 4 The forest plot is a visual representation of the effect of probiotic consumption: (A) BMI; (B) weight [31,32,33].
Figure 4 The forest plot is a visual representation of the effect of probiotic consumption: (A) BMI; (B) weight [31,32,33].CC BY · PubMed Central
Figure 5 The forest plot is a visual representation of the effect of probiotic consumption: (A) TGs; (B) TC; (C) LDL-C; (D) VLDL-C; (E) HDL-C; (F) total/HDL-cholesterol ratio [28,29,30,31,32,33].
Figure 5 The forest plot is a visual representation of the effect of probiotic consumption: (A) TGs; (B) TC; (C) LDL-C; (D) VLDL-C; (E) HDL-C; (F) total/HDL-cholesterol ratio [28,29,30,31,32,33].CC BY · PubMed Central
Figure 6 The forest plot is a visual representation of the effect of probiotic consumption: (A) glucose; (B) HOMA-IR; (C) insulin; (D) IRI; (E) QUICKI [28,29,30,31,32,33].
Figure 6 The forest plot is a visual representation of the effect of probiotic consumption: (A) glucose; (B) HOMA-IR; (C) insulin; (D) IRI; (E) QUICKI [28,29,30,31,32,33].CC BY · PubMed Central
Figure 7 The forest plot is a visual representation of the effect of probiotic consumption on inflammation [28,30].
Figure 7 The forest plot is a visual representation of the effect of probiotic consumption on inflammation [28,30].CC BY · PubMed Central
Figure 8 The forest plot is a visual representation of the effect of probiotic consumption: (A) GSH; (B) TAC; (C) MDA [28,30].
Figure 8 The forest plot is a visual representation of the effect of probiotic consumption: (A) GSH; (B) TAC; (C) MDA [28,30].CC BY · PubMed Central

Verification

Claims the paper makes

13 Valid · 1 Not valid · 9 Not checked · 41 Own results and interpretations

37 more claims · 1 with their cited sources checked

Create a free account to see all 64 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 13
  • It may state two separate claims as one. 12

Create a free account to see these claims.

Citations

Cites

Show all 60 references

Cited by

See all 8

Metadata

Authors
Li, L., Du, F., Liu, X., Song, M., Grosso, G., Battino, M., Boesch, C., Li, H., & Liu, X.
Affiliations
  • Beijing Technology and Business University (CN)
  • University of Catania (IT)
  • Jiangsu University (CN)
  • University of Leeds (GB)
Corresponding author
  • Li, Lu
  • Liu, Xinqi
Venue
Foods
Publisher
MDPI AG
Published
2025-05-16
Volume
14
Issue
10
Pages
1773
ISSN
2304-8158 (ISSN-L)
OpenAlex
W4410439031
Cited by
8
References
60
Citations by year
2026: 8
FWCI
0.54
Type
journal article
Language
en
Open access
Locations
  • Foods (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion, cc-by)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
probiotics, schizophrenia, psychiatric symptoms, body weight, body mass index, lipid profile, cholesterol, glycemic control, insulin sensitivity, insulin resistance, inflammation, oxidative stress, gut microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Supplementation with Probiotics in Patients with Schizophrenia: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials. https://app.cochat.ai/papers/10.3390/foods14101773
The paper
Li, L., Du, F., Liu, X., Song, M., Grosso, G., Battino, M., Boesch, C., Li, H., & Liu, X. (2025). Effect of Supplementation with Probiotics in Patients with Schizophrenia: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials. Foods. https://doi.org/10.3390/foods14101773

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.